Psychotic Disorder as the First Manifestation of Addison Disease: A Case Report

被引:4
|
作者
Sanat, Zahra Momayez [1 ]
Mohajeri-Tehrani, Mohammad Reza [2 ]
机构
[1] Univ Tehran Med Sci, Digest Dis Res Inst, Shariati Hosp, Tehran, Iran
[2] Univ Tehran Med Sci, Shariati Hosp, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran
关键词
Addison Disease; Psychotic Disorder; Depression; Sleep Disturbance;
D O I
10.5812/ijem.121011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Addison disease is a relatively uncommon endocrine disease resulting from adrenal insufficiency. Psychiatric symptoms are among its rare primary and particularly isolated clinical symptoms. This report presents a case with adrenal insufficiency manifested by the psychotic syndrome. Case Presentation: A28-year-old Iranian female with a history of immune thrombocytopenic purpura (ITP) and asthma since childhood presented with a 13-month history of progressive depression with insomnia and nightmare symptoms. After being prescribed haloperidol, clomipramine, and clonazepam for eight months, abdominal pain and weight loss due to anorexia started. Her physical examination showed skin hyperpigmentation in the elbow, knee, ankle, and buccal mucosa. Physical examination and initial laboratory tests suggested adrenal insufficiency. Addison disease was confirmed according to the laboratory tests and abdominal CT. The symptoms were significantly improved using intravenous hydrocortisone treatment. The patient remained calm and had a normal sleep without depressive symptoms or psychosis after 72 hours of treatment. During one year of follow-up, the patient was in good general condition without psychological symptoms. Conclusions: This report shows that psychotic disorder can be the first manifestation of Addison disease. Therefore, physicians should be informed about the neuropsychiatric symptoms of adrenal insufficiency, especially when the patient lacks a family or personal history of psychiatric illness.
引用
收藏
页数:5
相关论文
共 50 条
  • [22] Synthetic Cannabinoid Receptor Agonist-Associated Psychotic Disorder: A Case Report
    Sonmez, Ipek
    Kosger, Ferdi
    TURK PSIKIYATRI DERGISI, 2016, 27 (01) : 63 - 66
  • [23] The Emergence of a Psychotic Disorder With a Diagnosis of Breast Cancer Metastasized to the Brain: A Case Report
    Yildirim, Tugce Talar
    Yildiz, Sevler
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [24] Late-onset psychotic disorder with a history of carbon monoxide poisoning: A case report
    Salihoglu, Gozde
    Hocaoglu, Cicek
    KLINIK PSIKIYATRI DERGISI-TURKISH JOURNAL OF CLINICAL PSYCHIATRY, 2021, 24 (03): : 420 - 426
  • [25] Psychotic depression as an initial symptom of Huntington's disease - a case report
    Salagierska, Joanna
    Remlinger-Molenda, Agnieszka
    Zielonka, Daniel
    Rybakowski, Janusz
    NEUROPSYCHIATRIA I NEUROPSYCHOLOGIA, 2016, 11 (04): : 148 - 151
  • [26] Primarily depression manifestation of Wilson's disease-Case report
    Kulak-Bejda, A.
    Waszkiewicz, N.
    Galinska-Skok, B.
    Zajkowska, A.
    Kulakowska, A.
    Kochanowicz, J.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2020, 190
  • [27] Psychotic disorder, hypertension and seizures associated with vitamin B12 deficiency: a case report
    Dogan, M.
    Ariyuca, S.
    Peker, E.
    Akbayram, S.
    Dogan, S. Z.
    Ozdemir, O.
    Cesur, Y.
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2012, 31 (04) : 410 - 413
  • [28] Differential diagnosis of anorexia nervosa and depression. A case report of Addison's disease in a female patient
    Steiner, J
    Zajontz, H
    Reiss, S
    Bogerts, B
    NERVENARZT, 2006, 77 (03): : 338 - 342
  • [29] Erythema induratum of Bazin associated with Addison's disease: first description
    Brandao Neto, Rodrigo Antonio
    de Carvalho, Jozelio Freire
    SAO PAULO MEDICAL JOURNAL, 2012, 130 (06): : 405 - 408
  • [30] Psychotic disorder related to levetiracetam usage: report of two cases
    Erdogan, Serap
    Aslan, Selcuk
    Yuksel, Nevzat
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 19 (04): : 420 - 422